Printed from Voxsanity (voxsanity.com.au) — NCT06232434 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Stomach Cancer
Phase 3 Stomach Cancer Trial, Recruiting
NCT06232434
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have stomach cancer (that has not spread to the food pipe/esophagus) that has spread to the lining of the abdomen (peritoneum), at various stages of spread to lymph nodes.
- Doctors expect you to live for at least 6 months.
- You are generally able to carry out daily activities with little to no limitation (confirm with trial site regarding exact fitness level required).
- You are between 18 and 75 years old.
- You do not have any other serious health conditions that are currently uncontrolled or in a critical stage.
- You are willing and able to sign a written consent form to take part in the study.
- You (and any carers helping you) are able to follow the instructions given by the research team and meet the requirements of the study.
Who may not be able to join:
- You are pregnant or currently breastfeeding.
- You have been diagnosed with another type of cancer at the same time or in the past, unless it was a certain skin cancer, cervical cancer in situ, or another cancer treated and fully cured more than 5 years ago.
- You have another serious health condition that is currently uncontrolled or in a critical stage.
- You are a family member of someone working at the trial centre.
- You have a known allergy to any ingredient in the study medication.
- You do not wish to receive the treatment being studied.
- You have a serious heart condition (classified as Class III or IV severity), or you had a heart attack within the last 6 months.
- You have ever had an epileptic seizure.
- You have a serious illness, including untreated infections or inflammatory conditions, that would prevent you from following the study treatment plan.
- You have long-term (chronic) liver or kidney failure.
- You or your close family are unable to understand what the treatment involves or what its effects might be, for any reason.
- Your personal situation (for example, where you live or your financial circumstances) makes it difficult to reliably attend appointments and follow the study plan.
- You have had a problem with alcohol or substance misuse in the 2 years leading up to 10 days before the study starts.
- You are currently taking part in another clinical trial.
- You are currently experiencing active bleeding from the tumour.
- Your blood test results show that your white blood cell count, platelet count, or haemoglobin (red blood cell) levels are too low (confirm specific numbers with trial site).
- You have tested positive for HIV, hepatitis B, or hepatitis C.
- Your liver is not functioning well enough, based on specific blood test results (confirm with trial site).
- Your kidneys are not functioning well enough, based on how well they filter waste from your blood (confirm with trial site).
- You have diabetes that is currently poorly controlled.
During the study, you may be asked to leave if:
- You have a bad reaction to the study medication.
- You decide you no longer wish to take part.
- You experience a serious side effect or health problem during the study.
- You are unable to follow the study rules or take the medication as required.
- You become pregnant during the study.
- A second cancer is discovered.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
Contact this trial
Phone: +375 17 209-52-54
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 3
Sponsor
Research Institute for Physical Chemical Problems of the Belarusian State University
Registry
ClinicalTrials.gov
Start date
20 June 2025
Est. completion
1 December 2025
Where this trial is recruiting
Belarus
Primary endpoints
increased survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.